High Throughput Screening (HTS) Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global high throughput screening (HTS) market looks promising with opportunities in the pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CRO). The global high throughput screening (HTS) market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are growing adoption of open innovation models in pharmaceutical and biotechnology companies, increasing R&D spending, and the availability of government funding and venture capital investments.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global high throughput screening (HTS) market report, please download the report brochure.
In this market, reagents and assay kits is the fastest growing product and service type of high throughput screening (HTS). Growth in various segments of the high throughput screening (HTS) market are given below:
The study includes trends and forecast for the global high throughput screening (HTS) market by by product & service, technology, application, detection method, end user, and region as follows:
By Product & Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents & Assay Kits
Instruments
Consumables & Accessories
Software
Services
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Cell-Based Assays
2D Cell Culture
3D Cell Culture
Scaffold-Based Technology
Scaffold-Free Technology
Perfusion Cell Culture
Reporter Based Assays
Lab-On-A-Chip
Ultra-High-Throughput Screening
Bioinformatics
Label-Free Technology
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Drug Discovery
Target Identification and Validation
Primary and Secondary Screening
Toxicology Assessment
Chemical Biology Programs
Cell- & Organ-Based Screening
Biochemical Screening
Biological Active Compound Screening
Genomics
Proteomics
Compound Profiling
By Detection Method [Value ($ Million) shipment analysis for 2014 – 2025]:
Mass Spectrometry (MS)
Chromatography
Calorimetry
X-Ray Diffraction
Other Detection Methods
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations (CRO)
Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
Spain
Italy
France
Asia Pacific
China
Japan
India
The Rest of the World
Brazil
Some of the metagenomics companies profiled in this report include Agilent Technologies, Danaher, Thermofisher Scientific, PerkinElmer, Tecan Group, Merck Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam, and Aurora Biomed.
Lucintel forecasts that reagents & assay kits will remain the largest product and service segment over the forecast period, primarily be attributed to factors, such as the large number of reagents and assay kits used in HTS techniques, rising prevalence of a number of diseases, increasing pharmaceutical R&D, and increased government funding for life science research.
Within this market, pharmaceutical & biotechnology companies will remain the largest application type segment over the forecast period, primarily driven by the extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications along with increasing pharmaceutical R&D expenditure.
North America will remain the largest region over the forecast period due to large spending on pharmaceutical R&D, the growing adoption of HTS, and availability of government funding in this region.
Features of the Global High Throughput Screening (HTS) Market
Market Size Estimates: Global high throughput screening (HTS) market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global high throughput screening (HTS) market size by various segments, such as by product & service, technology, application, detection method, and end user in terms of value.Regional Analysis: Global high throughput screening (HTS) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different by product & service, technology, application, detection method, end user, and region for the global high throughput screening (HTS) market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global high throughput screening (HTS) market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global high throughput screening (HTS) market product & service (reagents & assay kits, instruments, consumables & accessories, software, and services), technology (cell-based assays (2D cell culture, 3D cell culture (scaffold-based technology and scaffold-free technology), perfusion cell culture, and reporter based assays), lab-on-a-chip, ultra-high-throughput screening, bioinformatics, and label-free technology), application (drug discovery (target identification and validation, primary and secondary screening, and toxicology assessment), chemical biology programs, cell- & organ-based screening, biochemical screening, biological active compound screening, genomics, proteomics, and compound profiling), detection method (mass spectrometry (MS), chromatography, calorimetry, x-ray diffraction, and other detection methods), end user (pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CRO), and other end users) and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global high throughput screening (HTS) market?
Q.5 What are the business risks and threats to the global high throughput screening (HTS) market?
Q.6 What are the emerging trends in this high throughput screening (HTS) market and the reasons behind them?
Q.7 What are some changing demands of customers in this high throughput screening (HTS) market?
Q.8 What are the new developments in this high throughput screening (HTS) market? Which companies are leading these developments?
Q.9 Who are the major players in this high throughput screening (HTS) market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this high throughput screening (HTS) market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global high throughput screening (HTS) market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Service (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services), Technology (Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology), Application (Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling), Detection Method (Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods), and End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (Germany, United Kingdom, Spain, Italy, and France), Asia (China, Japan, and India), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global high throughput screening (HTS) market looks promising with opportunities in the pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CRO). The global high throughput screening (HTS) market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are growing adoption of open innovation models in pharmaceutical and biotechnology companies, increasing R&D spending, and the availability of government funding and venture capital investments.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global high throughput screening (HTS) market report, please download the report brochure.
In this market, reagents and assay kits is the fastest growing product and service type of high throughput screening (HTS). Growth in various segments of the high throughput screening (HTS) market are given below:
The study includes trends and forecast for the global high throughput screening (HTS) market by by product & service, technology, application, detection method, end user, and region as follows:
By Product & Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents & Assay Kits
Instruments
Consumables & Accessories
Software
Services
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Cell-Based Assays
2D Cell Culture
3D Cell Culture
Scaffold-Based Technology
Scaffold-Free Technology
Perfusion Cell Culture
Reporter Based Assays
Lab-On-A-Chip
Ultra-High-Throughput Screening
Bioinformatics
Label-Free Technology
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Drug Discovery
Target Identification and Validation
Primary and Secondary Screening
Toxicology Assessment
Chemical Biology Programs
Cell- & Organ-Based Screening
Biochemical Screening
Biological Active Compound Screening
Genomics
Proteomics
Compound Profiling
By Detection Method [Value ($ Million) shipment analysis for 2014 – 2025]:
Mass Spectrometry (MS)
Chromatography
Calorimetry
X-Ray Diffraction
Other Detection Methods
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations (CRO)
Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
Spain
Italy
France
Asia Pacific
China
Japan
India
The Rest of the World
Brazil
Some of the metagenomics companies profiled in this report include Agilent Technologies, Danaher, Thermofisher Scientific, PerkinElmer, Tecan Group, Merck Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam, and Aurora Biomed.
Lucintel forecasts that reagents & assay kits will remain the largest product and service segment over the forecast period, primarily be attributed to factors, such as the large number of reagents and assay kits used in HTS techniques, rising prevalence of a number of diseases, increasing pharmaceutical R&D, and increased government funding for life science research.
Within this market, pharmaceutical & biotechnology companies will remain the largest application type segment over the forecast period, primarily driven by the extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications along with increasing pharmaceutical R&D expenditure.
North America will remain the largest region over the forecast period due to large spending on pharmaceutical R&D, the growing adoption of HTS, and availability of government funding in this region.
Features of the Global High Throughput Screening (HTS) Market
Market Size Estimates: Global high throughput screening (HTS) market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global high throughput screening (HTS) market size by various segments, such as by product & service, technology, application, detection method, and end user in terms of value.Regional Analysis: Global high throughput screening (HTS) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different by product & service, technology, application, detection method, end user, and region for the global high throughput screening (HTS) market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global high throughput screening (HTS) market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global high throughput screening (HTS) market product & service (reagents & assay kits, instruments, consumables & accessories, software, and services), technology (cell-based assays (2D cell culture, 3D cell culture (scaffold-based technology and scaffold-free technology), perfusion cell culture, and reporter based assays), lab-on-a-chip, ultra-high-throughput screening, bioinformatics, and label-free technology), application (drug discovery (target identification and validation, primary and secondary screening, and toxicology assessment), chemical biology programs, cell- & organ-based screening, biochemical screening, biological active compound screening, genomics, proteomics, and compound profiling), detection method (mass spectrometry (MS), chromatography, calorimetry, x-ray diffraction, and other detection methods), end user (pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CRO), and other end users) and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global high throughput screening (HTS) market?
Q.5 What are the business risks and threats to the global high throughput screening (HTS) market?
Q.6 What are the emerging trends in this high throughput screening (HTS) market and the reasons behind them?
Q.7 What are some changing demands of customers in this high throughput screening (HTS) market?
Q.8 What are the new developments in this high throughput screening (HTS) market? Which companies are leading these developments?
Q.9 Who are the major players in this high throughput screening (HTS) market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this high throughput screening (HTS) market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global high throughput screening (HTS) market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Service (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services), Technology (Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology), Application (Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling), Detection Method (Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods), and End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (Germany, United Kingdom, Spain, Italy, and France), Asia (China, Japan, and India), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global High Throughput Screening (HTS) Market Trends and Forecast
3.3: Global High Throughput Screening (HTS) Market by Product & Service
3.3.1: Reagents & Assay Kits
3.3.2: Instruments
3.3.3: Consumables & Accessories
3.3.4: Software
3.3.5: Services
3.4: Global High Throughput Screening (HTS) Market by Technology
3.4.1: Cell-Based Assays
3.4.1.1: 2D Cell Culture
3.4.1.2: 3D Cell Culture
3.4.1.2.1: Scaffold-Based Technology
3.4.1.2.2: Scaffold-Free Technology
3.4.1.3: Perfusion Cell Culture
3.4.1.4: Reporter Based Assays
3.4.2: Lab-On-A-Chip
3.4.3: Ultra-High-Throughput Screening
3.4.4: Bioinformatics
3.4.5: Label-Free Technology
3.5: Global High Throughput Screening (HTS) Market by Application
3.5.1: Drug Discovery
3.5.1.1: Target Identification and Validation
3.5.1.2: Primary and Secondary Screening
3.5.1.3: Toxicology Assessment
3.5.2: Chemical Biology Programs
3.5.3: Cell- & Organ-Based Screening
3.5.4: Biochemical Screening
3.5.5: Biological Active Compound Screening
3.5.6: Genomics
3.5.7: Proteomics
3.5.8: Compound Profiling
3.6: Global High Throughput Screening (HTS) Market by Detection Method
3.6.1: Mass Spectrometry (MS)
3.6.2: Chromatography
3.6.3: Calorimetry
3.6.4: X-Ray Diffraction
3.6.5: Other Detection Methods
3.7: Global High Throughput Screening (HTS) Market by End User
3.7.1: Pharmaceutical and Biotechnology Companies
3.7.2: Academic and Government Institutes
3.7.3: Contract Research Organizations (CRO)
3.7.4: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global High Throughput Screening (HTS) Market by Region
4.2: North American High Throughput Screening (HTS) Market
4.2.1: Market by Product & Service: Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services
4.2.2: Market by Technology: Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology
4.2.3: Market by Application: Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling
4.2.4: Market by Detection Method: Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods
4.2.5: Market by End User: Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users
4.2.6: The United States High Throughput Screening (HTS) Market
4.2.7: The Canadian High Throughput Screening (HTS) Market
4.2.8: The Mexican High Throughput Screening (HTS) Market
4.3: European High Throughput Screening (HTS) Market
4.3.1: Market by Product & Service: Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services
4.3.2: Market by Technology: Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology
4.3.3: Market by Application: Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling
4.3.4: Market by Detection Method: Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods
4.3.5: Market by End User: Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users
4.3.6: The German High Throughput Screening (HTS) Market
4.3.7: The United Kingdom High Throughput Screening (HTS) Market
4.3.8: The Spain High Throughput Screening (HTS) Market
4.3.9: The Italy High Throughput Screening (HTS) Market
4.3.10: The French High Throughput Screening (HTS) Market
4.4: APAC High Throughput Screening (HTS) Market
4.4.1: Market by Product & Service: Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services
4.4.2: Market by Technology: Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology
4.4.3: Market by Application: Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling
4.4.4: Market by Detection Method: Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods
4.4.5: Market by End User: Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users
4.4.6: The Chinese High Throughput Screening (HTS) Market
4.4.7: The Indian High Throughput Screening (HTS) Market
4.4.8: The Japanese High Throughput Screening (HTS) Market
4.5: ROW High Throughput Screening (HTS) Market
4.5.1: Market by Product & Service: Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services
4.5.2: Market by Technology: Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology
4.5.3: Market by Application: Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling
4.5.4: Market by Detection Method: Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods
4.5.5: Market by End User: Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users
4.5.6: Brazilian High Throughput Screening (HTS) Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Product and Service
7.1.2: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Technology
7.1.3: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Application
7.1.4: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Detection Method
7.1.5: Growth Opportunities for the Global High Throughput Screening (HTS) Market by End User
7.1.6: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Region
7.2: Emerging Trends in the Global High Throughput Screening (HTS) Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global High Throughput Screening (HTS) Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Metagenomics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Agilent Technologies, Inc
8.2: Danaher
8.3: Thermofisher Scientific Inc.
8.4: Company
8.5: Company
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global High Throughput Screening (HTS) Market Trends and Forecast
3.3: Global High Throughput Screening (HTS) Market by Product & Service
3.3.1: Reagents & Assay Kits
3.3.2: Instruments
3.3.3: Consumables & Accessories
3.3.4: Software
3.3.5: Services
3.4: Global High Throughput Screening (HTS) Market by Technology
3.4.1: Cell-Based Assays
3.4.1.1: 2D Cell Culture
3.4.1.2: 3D Cell Culture
3.4.1.2.1: Scaffold-Based Technology
3.4.1.2.2: Scaffold-Free Technology
3.4.1.3: Perfusion Cell Culture
3.4.1.4: Reporter Based Assays
3.4.2: Lab-On-A-Chip
3.4.3: Ultra-High-Throughput Screening
3.4.4: Bioinformatics
3.4.5: Label-Free Technology
3.5: Global High Throughput Screening (HTS) Market by Application
3.5.1: Drug Discovery
3.5.1.1: Target Identification and Validation
3.5.1.2: Primary and Secondary Screening
3.5.1.3: Toxicology Assessment
3.5.2: Chemical Biology Programs
3.5.3: Cell- & Organ-Based Screening
3.5.4: Biochemical Screening
3.5.5: Biological Active Compound Screening
3.5.6: Genomics
3.5.7: Proteomics
3.5.8: Compound Profiling
3.6: Global High Throughput Screening (HTS) Market by Detection Method
3.6.1: Mass Spectrometry (MS)
3.6.2: Chromatography
3.6.3: Calorimetry
3.6.4: X-Ray Diffraction
3.6.5: Other Detection Methods
3.7: Global High Throughput Screening (HTS) Market by End User
3.7.1: Pharmaceutical and Biotechnology Companies
3.7.2: Academic and Government Institutes
3.7.3: Contract Research Organizations (CRO)
3.7.4: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global High Throughput Screening (HTS) Market by Region
4.2: North American High Throughput Screening (HTS) Market
4.2.1: Market by Product & Service: Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services
4.2.2: Market by Technology: Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology
4.2.3: Market by Application: Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling
4.2.4: Market by Detection Method: Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods
4.2.5: Market by End User: Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users
4.2.6: The United States High Throughput Screening (HTS) Market
4.2.7: The Canadian High Throughput Screening (HTS) Market
4.2.8: The Mexican High Throughput Screening (HTS) Market
4.3: European High Throughput Screening (HTS) Market
4.3.1: Market by Product & Service: Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services
4.3.2: Market by Technology: Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology
4.3.3: Market by Application: Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling
4.3.4: Market by Detection Method: Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods
4.3.5: Market by End User: Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users
4.3.6: The German High Throughput Screening (HTS) Market
4.3.7: The United Kingdom High Throughput Screening (HTS) Market
4.3.8: The Spain High Throughput Screening (HTS) Market
4.3.9: The Italy High Throughput Screening (HTS) Market
4.3.10: The French High Throughput Screening (HTS) Market
4.4: APAC High Throughput Screening (HTS) Market
4.4.1: Market by Product & Service: Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services
4.4.2: Market by Technology: Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology
4.4.3: Market by Application: Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling
4.4.4: Market by Detection Method: Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods
4.4.5: Market by End User: Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users
4.4.6: The Chinese High Throughput Screening (HTS) Market
4.4.7: The Indian High Throughput Screening (HTS) Market
4.4.8: The Japanese High Throughput Screening (HTS) Market
4.5: ROW High Throughput Screening (HTS) Market
4.5.1: Market by Product & Service: Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services
4.5.2: Market by Technology: Cell-Based Assays (2D Cell Culture, 3D Cell Culture (Scaffold-Based Technology and Scaffold-Free Technology), Perfusion Cell Culture, and Reporter Based Assays), Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology
4.5.3: Market by Application: Drug Discovery (Target Identification and Validation, Primary and Secondary Screening, and Toxicology Assessment), Chemical Biology Programs, Cell- & Organ-Based Screening, Biochemical Screening, Biological Active Compound Screening, Genomics, Proteomics, and Compound Profiling
4.5.4: Market by Detection Method: Mass Spectrometry (MS), Chromatography, Calorimetry, X-Ray Diffraction, and Other Detection Methods
4.5.5: Market by End User: Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations (CRO), and Other End Users
4.5.6: Brazilian High Throughput Screening (HTS) Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Product and Service
7.1.2: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Technology
7.1.3: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Application
7.1.4: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Detection Method
7.1.5: Growth Opportunities for the Global High Throughput Screening (HTS) Market by End User
7.1.6: Growth Opportunities for the Global High Throughput Screening (HTS) Market by Region
7.2: Emerging Trends in the Global High Throughput Screening (HTS) Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global High Throughput Screening (HTS) Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Metagenomics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Agilent Technologies, Inc
8.2: Danaher
8.3: Thermofisher Scientific Inc.
8.4: Company
8.5: Company
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
